Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Techlistamab. Look this up. Called miracle treatment for multiple myeloma. Used in England

A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA

Teclistamab (brand name Tecvayli) is a bispecific antibody used to treat adults with relapsed or refractory multiple myeloma. As a bispecific T-cell engager (BiTE), it helps activate the immune system to destroy myeloma cancer cells
How it works
Teclistamab functions by binding to two different types of proteins simultaneously to link immune cells and cancer cells together
Targeting myeloma cells: One "arm" of the antibody attaches to B-cell maturation antigen (BCMA), a protein found on the… read more

October 3, 2025
 · 
Reactions
MyMyelomaTeam

Teclistamab (Tecvayli) is an innovative bispecific T-cell engager (BiTE) approved by the FDA in 2022 for treating relapsed or refractory multiple myeloma. It works by targeting both BCMA on myeloma cells and CD3 protein on T cells, effectively bringing immune cells and cancer cells together to destroy the myeloma.

Clinical Show Full Answer

Teclistamab (Tecvayli) is an innovative bispecific T-cell engager (BiTE) approved by the FDA in 2022 for treating relapsed or refractory multiple myeloma. It works by targeting both BCMA on myeloma cells and CD3 protein on T cells, effectively bringing immune cells and cancer cells together to destroy the myeloma.

Clinical trials showed impressive results with an overall response rate of 62%, meaning nearly two-thirds of patients saw improvement in their condition. A key advantage of teclistamab is that it's an "off-the-shelf" treatment, meaning it doesn't need to be specially manufactured for each patient. This makes it more readily available and accessible compared to some other treatment options.

The treatment is administered through subcutaneous injection and is specifically approved for adults who have already tried at least three prior lines of therapy. Always discuss potential side effects and eligibility with your healthcare team before starting any new treatment.

October 3, 2025

Related Questions

View All

Has anyone used Ivemectrin for multiple myeloma treatment

A MyMyelomaTeam Member asked a question 💭
Salisbury, MD
February 4

What are treatment options for smoldering myeloma?

A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA
March 3

Bispecifics for Relapsed and Refractory Multiple Myeloma Patients

A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA
June 13, 2025

7 Symptoms of Multiple Myeloma Relapse
7 Ways To Avoid Stopping Treatment for Multiple Myeloma
Myeloma Relapse Rates and 9 Treatment Options for Relapses